Antiinflammatory and Analgesic Effects of Somatostatin Released from Capsaicin-Sensitive Sensory Nerve Terminals in a Freund's Adjuvant-Induced Chronic Arthritis Model in the Rat

Arthritis and Rheumatism

Volumn 50, Issue 5, 2004, Pages 1677-1685

  Helyes, Zsuzsanna ^a   Szabó, Árpád ^a   Németh, József ^b   Jakab, Balázs ^a   Pintér, Erika ^a   Bánvölgyi, Ágnes ^a   Kereskai, László ^a   Kéri, György ^c   Szolcsányi, János ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CYCLOSOMATOSTATIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLCYSTEINYLTHREONINAMIDE 2,6 DISULFIDE; FREUND ADJUVANT; HEPTAPEPTIDE AGONIST; RESINIFERATOXIN; SOMATOSTATIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE EROSION; CARTILAGE DEGENERATION; CELL INFILTRATION; CHRONIC ARTHRITIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HYPERALGESIA; IMMUNOREACTIVITY; INFLAMMATION; MALE; NERVE ENDING; NOCICEPTION; NONHUMAN; PAW EDEMA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SENSORY NERVE; SOMATOSTATIN RELEASE;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DITERPENES; EDEMA; FREUND'S ADJUVANT; HINDLIMB; MALE; PEPTIDES, CYCLIC; RATS; RATS, INBRED LEW; RECEPTORS, DRUG; RECEPTORS, SENSORY; SOMATOSTATIN;

EID: 2342555611     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20184     Document Type: Article

References (54)

1. Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 1995;45:1-98.
2. Szolcsanyi J. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. Prog Brain Res 1996;113:343-59.
3. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-68.
4. Ferrell WR, Lam FY. Sensory neuropeptides in arthritis. In: Geppetti P, Holzer P, editors. Neurogenic inflammation. Boca Raton (FL): CRC Press; 1996. p. 211-27.
5. Helyes Z, Pinter E, Nemeth J, Szolcsanyi J. Pharmacological targets for the inhibition of neurogenic inflammation. Curr Med Chem AIAAA 2003;2:191-218.
6. Lam FY, Ferrell WR. Neurogenic component of different models of acute inflammation in the rat knee joint. Ann Rheum Dis 1991;50:747-51.
7. Jorgenson C, Sany J. Modulation of the immune response by the neuro-endocrine axis in rheumatoid arthritis. Clin Exp Rheumatol 1994;12:435-41.
8. Marabini S, Matucci-Cerinic M, Geppetti P, Del Blanco E, Marchesoni A, Tosi S, et al. Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid. Ann N Y Acad Sci 1991;632:435-6.
9. Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorsson E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 1991;20:326-35.
10. Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E. Bilateral changes of substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett 1993;153:37-40.
11. Parsons CG, Czlonkowski A, Stein C, Herz A. Peripheral opioid receptors mediating antinociception in inflammation: activation by endogenous opioids and role of the pituitary-adrenal axis. Pain 1990;41:81-93.
12. Heppelmann B, Just S, Pawlak M. Galanin influences the mechanosensitivity of sensory endings in the rat knee joint. Eur J Neurosci 2000;12:1567-72.
13. Delgado M, Abad C, Martinez C, Juarranz MG, Arranz A, Gomariz RP, et al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med 2002;80:16-24.
14. Delgado M, Abad C, Martinez C, Juarranz MG, Leceta J, Ganea D, et al. PACAP in immunity and inflammation. Ann N Y Acad Sci 2003;992:141-57.
15. Fioravanti A, Govoni M, La Montagna G, Perpignano G, Tirri G, Trotta F, et al. Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Exp Clin Res 1995;21:97-103.
16. Matucci-Cerinic M, Marabini S. Somatostatin treatment for pain in rheumatoid arthritis: a double blind versus placebo study in knee involvement. Med Sci Res 1998;16:233-34.
17. Sakane T, Suzuki N. The role of somatostatin in the pathophysiology of rheumatoid arthritis. Clin Exp Rheumatol 1998;16:745-9.
18. Karalis K, Mastorakos G, Chrousos GP, Tolis G. Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest 1994;93:2000-6.
19. Pinter E, Helyes Z, Nemeth J, Porszasz R, Petho G, Than M, et al. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol 2002;366:142-50.
20. Helyes Z, Than M, Oroszi G, Pinter E, Nemeth J, Keri Gy, et al. Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci Lett 2000;278:185-8.
21. Szolcsanyi J, Helyes Z, Oroszi G, Nemeth J, Pinter E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 1998;123:936-42.
22. Szolcsanyi J, Pinter E, Helyes Z, Oroszi G, Nemeth J. Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol 1998;125:916-22.
23. Than M, Nemeth J, Szilvassy Z, Pinter E, Helyes Z, Szolcsanyi J. Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibres of the rat and guinea-pig. Eur J Pharmacol 2000;399:251-8.
24. Keri G, Mezo I, Vadasz Z, Horvath A, Idei M, Vantus T, et al. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Pept Res 1993;6:281-8.
25. Keri G, Erchegyi J, Horvath A, Mezo I, Idei M, Vantus T, et al. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci U S A 1996;93:12513-8.
26. Helyes Z, Pinter E, Nemeth J, Keri G, Than M, Oroszi G, et al. Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br J Pharmacol 2001;134:1571-9.
27. Nemeth J, Helyes Z, Gorcs T, Gardi J, Pinter E, Szolcsanyi J. Development of somatostatin radioimmunoassay for the measurement of plasma and tissue contents of hormone. Acta Physiol Hung 1996;84:313-5.
28. 125I-labelling and purification of peptide hormones and bovine serum albumine. J Radioanal Nucl Chem 2002;251:129-33.
29. Schwab W, Bilgicyildirim A, Funk RH. Microtopography of the autonomic nerves in the rat knee: a fluorescence microscopic study. Anat Rec 1997;247:109-18.
30. Weinberger A, Halpern M, Zahalka MA, Quintana F, Traub L, Moroz C. Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis. Arthritis Rheum 1997;48:846-53.
31. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
32. Kar S, Gibson SJ, Rees RG, Jura WG, Brewerton DA, Polak JM. Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply. J Mol Neurosci 1991;3:7-18.
33. Donaldson LF, Harmar AJ, McQueen DS, Secki JR. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Brain Res Mol Brain Res 1992;16:143-9.
34. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A. Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis: a combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995;38:699-709.
35. Ahmed M, Bjurholm A, Srinivasan GR, Lundeberg T, Theodorsson E, Schultzberg M, et al. Capsaicin effects on substance P and CGRP in rat adjuvant arthritis. Regul Pept 1995;55:85-102.
36. Gamse R, Leeman SE, Holzer P, Lembeck F. Differential effects of capsaicin on the content of somatostatin, substance P, and neurotensin in the nervous system of the rat. Naunyn Schmiedebergs Arch Pharmacol 1981;317:140-8.
37. Ahmed M, Srinivasan GR, Theodorsson E, Schultzberg M, Kreicbergs A. Effects of surgical denervation on substance P and calcitonin gene-related peptide in adjuvant arthritis. Peptides 1995;16:569-79.
38. Elhassan AM, Adem A, Hultenby K, Lindgren JU. Somatostatin immunoreactivity in bone and joint tissues. Neuroreport 1998;9:2573-5.
39. Elhassan AM, Lindgren JU, Hultenby K, Adem A. Increased levels of somatostatin in rat ankles with adjuvant arthritis. Rheumatol Int 2001;20:186-91.
40. Pinter E, Helyes Z, Nemeth J, Szolcsanyi J. Somatostatin as an anti-inflammatory neuropeptide: from physiological basis to drug development. In Fischer A, Jancso G, editors. Neurogenic inflammation, neuroimmune biology. Vol. V. Amsterdam: Elsevier Science; in press.
41. Krantic S. Peptides as regulators of the immune system: emphasis on somatostatin. Peptides 2000;21:1941-64.
42. Kolasinski SL, Haines KA, Siegel EL, Cronstein BN, Abramson SB. Neuropeptides and inflammation: a somatostatin analog as a selective antagonist of neutrophil activation by substance P. Arthritis Rheum 1992;35:369-75.
43. Dingle JT, Page-Thomas DP, Hazleman B. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation. Int J Tissue React 1987;9:349-54.
44. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5.
45. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PP, et al. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci 1995;16:86-8.
46. Takeba Y, Suzuki N, Takeno M, Asai T, Tsuboi S, Hoshino T, et al. Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis. Arthritis Rheum 1997;40:2128-38.
47. Carlton SM, Zhou S, Kraemer B, Coggeshall RE. A role for peripheral somatostatin receptors in counter-irritation-induced analgesia. Neuroscience 2003;120:499-508.
48. Ten Bokum AM, Lichtenauer-Kaligis EG, Melief MJ, van Koetsveld PM, Bruns C, van Hagen PM, et al. Somatostatin receptor subtype expression in cells of the rat immune system during adjuvant arthritis. J Endocrinol 1999;161:167-75.
49. Ten Bokum AM, Hofland LJ, van Hagen PM. Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw 2000;11:161-76.
50. Heppelmann B, Pawlak M. Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat. Pain 1997;73:377-82.
51. Carlton SM, Du J, Davidson E, Zhou S, Coggeshall RE. Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors. Pain 2001;90:233-44.
52. Matucci-Cerinic M, Borrelli F, Generini S, Cantelmo A, Marcucci I, Martelli F, et al. Somatostatin-induced modulation of inflammation in experimental arthritis. Arthritis Rheum 1995;38:1687-93.
53. Corsi MM, Ticozzi C, Netti C, Fulgenzi A, Tiengo M, Gaja G, et al. The effect of somatostatin on experimental inflammation in rats. Anesth Analg 1997;85:1112-5.
54. Kurnatowska I, Pawlikowski M. Effect of somatostatin analog-octreotide on the adjuvant arthritis in rat. Neuroendocrinol Lett 2000;21:121-6.